North Carolina Peptide Research Regulatory Overview
Federal and state regulatory context for research-grade peptide compounds in North Carolina. Informational summary for scientific researchers and research institutions.
Disclaimer: This page provides general regulatory context for informational purposes only and does not constitute legal advice. Researchers should consult applicable federal and state regulations and qualified legal counsel before making any decisions based on this content.
Federal Regulatory Context
Research-grade peptide compounds including BPC-157, TB-500, GHK-Cu, NAD+, and Epithalon are not currently listed under any federal DEA controlled substance schedule and are available for legitimate in vitro laboratory research without DEA registration requirements applicable to scheduled substances. These compounds are governed by the FDA Research Use Only framework that requires commercial sale and use for scientific research purposes only.
North Carolina State Context
The North Carolina Controlled Substances Act tracks federal CSA scheduling and does not currently impose scheduling restrictions on unscheduled research-grade peptide compounds. North Carolina does not maintain a state analog act applicable to standard research peptide compound classes. Researchers at North Carolina institutions should confirm applicable regulations with institutional compliance offices and consult qualified legal counsel for guidance specific to their research program and institutional context.
Research Overview
North Carolina is home to Research Triangle Park, one of the largest research parks in the world, as well as Duke University School of Medicine, UNC Chapel Hill School of Medicine, North Carolina State University College of Veterinary Medicine, and Wake Forest University School of Medicine. This cluster of research institutions conducts extensive preclinical and translational research in peptide biology, pharmacology, and biochemistry. The North Carolina Controlled Substances Act (G.S. Chapter 90, Article 5) establishes state scheduling that mirrors federal CSA scheduling and does not currently impose scheduling restrictions on unscheduled research-grade peptide compounds. Researchers in North Carolina should operate within institutional compliance frameworks for research chemical procurement and use.
- •Duke University School of Medicine
- •UNC Chapel Hill School of Medicine
Commonly Researched Compounds
Research-grade compounds commonly procured by institutions in North Carolina for in vitro and preclinical research programs.
Frequently Asked Questions
Legal Disclaimer
The information on this page is provided for general informational and educational purposes only. It does not constitute legal advice and should not be relied upon as such. Laws and regulations governing research chemicals, peptides, and related compounds vary by jurisdiction and are subject to change. Researchers and organizations should consult a qualified legal professional familiar with federal and state law applicable to their specific situation before making any decisions based on this content. Spartan Peptides does not provide legal counsel and makes no representations regarding the legal status of any compound in any specific jurisdiction.
Explore All Research-Grade Compounds
Browse the full Spartan Peptides research compound catalog. All compounds are research-grade, supplied as lyophilized powder with certificate of analysis, for in vitro laboratory research use only.